This randomized clinical trial evaluates whether culturally based palliative care video consultation in rural hospitals without palliative care services improves symptom distress among inpatients with serious illnesses compared with usual care.
Key Points
Question
Is community-developed, culturally based palliative care video consultation in rural hospitals without palliative care services superior to usual care in improving symptom distress in Black or African American and White inpatients admitted with serious illnesses?
Findings
In this randomized clinical trial of 209 inpatients, mean symptom distress score change at day 7 was −11.4 points for video consultation vs −7.3 points for usual care. The between-group difference in scores was not statistically significant but met the criteria for a minimal clinically important difference (3-4 points).
Meaning
Palliative video consultation to reduce health care inequities for hospitalized rural-dwelling individuals may warrant further investigation.
Abstract
Importance
Palliative care has been shown to improve important patient outcomes but is rarely available in small or rural hospitals.
Objective
To assess whether culturally based palliative care video consultation could improve symptom distress compared with usual inpatient care without palliative care.
Design, Setting, and Participants
Recruitment for this multisite, single-blind randomized clinical trial occurred from July 20, 2020, to December 20, 2023; data collection was completed on January 15, 2024. A community-aided approach was used to recruit inpatients from 3 rural hospitals lacking palliative care services in Alabama, Mississippi, and South Carolina. Self-identified non-Hispanic Black or African American and non-Hispanic White adults aged 55 years or older admitted with a serious chronic illness and a willing caregiver were invited to participate. Randomization was stratified by site and race.
Interventions
Participants were randomized 1:1 to Community Tele-Pal, culturally based video consultation by a palliative care specialist followed by research coordinator (RC) contacts 3 and 6 days after video consultation (intervention arm), or to routine hospital care (control arm).
Main Outcomes and Measures
The primary outcome was the between-group difference in the change in patient-reported symptom distress from baseline to day 7, assessed by the Edmonton Symptom Assessment Scale (ESAS; range, 0-90; lower scores indicate lower symptom distress). Secondary outcomes were quality of life (QOL; Patient-Reported Outcomes Measurement Information System global physical and mental health mean T scores), resource use (emergency department visits and hospital readmissions), and an exploratory outcome of feeling heard and understood.
Results
A total of 209 patients were randomized (104 to usual care; 105 to the intervention); mean (SD) age was 73.3 (8.3) years, 120 (57.4%) were female, 58 (27.8%) were Black or African American, 157 (75.1%) were retired, and 75 (35.9%) had a Palliative Performance Scale score less than 70% (indicating need for functional assistance). On day 7, the mean (SE) ESAS score change from baseline was −11.4 (1.5) points in the intervention group and −7.3 (1.5) points in the control group; the between-group difference in change in ESAS scores was not statistically significant (Westfall d, −0.28; 95% CI, −0.56 to 0.01; P = .055). The mean (SE) day 7 between-group difference in ESAS score of −4.0 (1.8) points met the criteria for a minimal clinically important difference of 3 to 4 points. No between-group differences were observed for QOL, resource use, or feeling heard and understood.
Conclusions and Relevance
In this randomized clinical trial, the intervention was not associated with reduced symptom distress at day 7 vs baseline or with improved QOL or reduced resource use compared with usual care. However, the between-group difference in the ESAS score met the criteria for a minimal clinically important difference of 3 to 4 points. Palliative video consultation to reduce health care inequities for hospitalized rural-dwelling individuals may warrant further investigation.
Trial Registration
ClinicalTrials.gov Identifier: NCT03767517
Introduction
The triple threat of rural geography, racial inequities, and older age has hindered access to high-quality palliative care for many people in the US.1,2,3,4,5,6,7,8 The rural southeastern US has few facilities offering palliative care. Only 70% of the deep South vs 85% to 94% of the rest of the US has palliative care7 despite the deep South having the greatest needs due to suboptimal health care access and elevated morbidity and mortality.6,8
Telehealth has been effective in providing specialty palliative care to rural and frontier areas,2,9,10,11,12 homes,13 and clinics.13,14,15 A prior study by our team, ENABLE (Educate, Nurture, Before Life Ends), pioneered delivery of early palliative care via telehealth to rural outpatients with cancer14,15 and heart failure16 and family caregivers.17,18,19 However, unlike rural hospital emergency medicine and intensive care,20,21 inpatient palliative care via telehealth is understudied. A retrospective study,22 case series,23,24 and reviews25,26,27 reported positive experiences with inpatient palliative care via telehealth, especially for the pandemic-induced surge of critically ill inpatients needing goals-of-care discussions. However, expanding inpatient palliative care via telehealth to areas with unique cultures, such as rural hospitals in the southeastern US, requires more than a technological connection.
Cultural considerations, highlighted by the National Consensus Project (NCP) guidelines, are essential to providing high-quality palliative care.28 Since initial palliative care studies were conducted in urban academic centers serving largely White, middle-class, educated populations,29,30,31 culturally diverse individuals with unique health and illness beliefs and historical mistrust of the medical system have been less receptive to palliative care.1,32,33,34 For example, despite some recent improvement,35 Black or African American persons historically have had the lowest hospice and palliative care use.3,36,37 Use of community-engaged methods, such as community-based participatory research (CBPR), has resulted in culturally responsive care strategies that may reduce health disparities in underrepresented populations.1,38,39,40,41,42
While dimensions of rurality,2,9 culture,29,32 and telehealth9,11,13 have been individually addressed to improve palliative care access and acceptability, we aimed to synergize these efforts by implementing a community-developed video consultation strategy for rural hospitals without palliative care,43 especially for groups that traditionally have underused palliative care.1,3,28,34,43 First, using a CBPR approach, a prior study by our team partnered with southern, rural Black and White community members and conducted focus groups for caregivers of hospitalized seriously ill patients to culturally and linguistically elevate their voices about practices that respected their cultural values and beliefs.28,43 Each group’s beliefs and communication preferences were incorporated into the NCP-recommended standard palliative care consultation.29 Second, community experts were leveraged to provide our team with a cultural immersion experience to provide a deep understanding of and insights on cultural values and communication preferences.43 The community experts proposed simple acts like addressing patients respectfully as “Mr” or “Mrs,” establishing rapport by conversing about the local community, avoiding medical jargon, and respecting how cultural and religious lenses impacted patients’ health and illness beliefs. Third, community advisory boards (CABs) were established at each site to gain community-informed insights about acceptable study procedures. Fourth, CAB members were engaged as recruitment ambassadors38 and were provided a stipend for each recruitment visit.
The purpose of this multisite randomized clinical trial (RCT) was to evaluate whether community-developed, culturally based palliative care video consultation could improve symptom distress, quality of life (QOL), and resource use 44 compared with usual care in hospitals without palliative care; an exploratory outcome of feeling heard and understood was also assessed. We hypothesized that culturally based video consultation would be superior to usual hospital care in reducing symptom distress and improving resource use and QOL.
Methods
Design
In accordance with the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline for RCTs,45 Community Tele-Pal was a 3-site, single-blind RCT with 1:1 allocation to the video consultation intervention43,46 or usual care among seriously ill older adults. The University of Alabama at Birmingham, Russell Medical Center, Aiken Medical Center, and Anderson Medical Center institutional review boards approved the study protocol46 and analytic plan (Supplement 1). The trial was registered at ClinicalTrials.gov (NCT03767517) prior to startup. Patients and caregivers individually provided written informed consent.
Participants
Eligible patients self-identified as non-Hispanic Black or African American or non-Hispanic White because the original intervention development study included only Black and White non-Hispanic individuals. The intervention was only designed for cultural considerations of non-Hispanic Black or White patients, and during screening, those self-identifying as another race or as Hispanic ethnicity were not eligible and were not approached to participate. Eligible patients were also aged 55 years or older, had cancer or predefined noncancer serious chronic illness47 (eAppendix 1 in Supplement 2), had a Callahan cognitive screen score of 3 or higher,48 had a participating caregiver (defined as someone who knew the patient well and was involved in their care),18,19 and completed baseline measures. Patient exclusion criteria were receiving hospice care; not home dwelling; self-identified race other than Black or African American or White or ethnicity other than non-Hispanic; currently using recreational drugs; and having schizophrenia, bipolar disorder, or alcohol misuse. Eligible caregivers were willing to participate and complete baseline measures. Patients and caregivers received $40 ($10 at baseline, $10 at day 7, and $20 at day 30) for completing outcome measures.
Settings and Recruitment
Recruitment occurred between July 20, 2020, and December 20, 2023; data collection was completed on January 15, 2024. The 3 rural-serving hospitals (in Alabama, South Carolina, and Mississippi) lacked palliative care and had sufficient non–intensive care unit admissions to meet recruitment goals (eTable 1 in Supplement 2). Site teams comprised a local hospitalist, blinded and unblinded research coordinators, an 8-member CAB (comprising health care professionals, community leaders, patients and family members, and faith leaders), and remote culturally trained board-certified palliative care clinicians.
Local research coordinators screened medical admissions daily and, with hospitalist agreement, used a community-informed recruitment approach wherein a racially concordant (when available) CAB member introduced themself and the study goals to eligible patients.38 (Until May 31, 2021, due to COVID-19 visitor restrictions, CAB members’ prerecorded videos were substituted for in-person approaches.38) After CAB introduction, research coordinators reviewed the completed informed consent and baseline questionnaires from patients and caregivers agreeable to the study.
Randomization and Blinding
The study statistician (R.K.) developed a computer-generated block randomization schema stratified by study site and self-identified (Black or African American, White) race. Following consent and completion of baseline questionnaires, the research coordinator notified the University of Alabama at Birmingham–based program manager (F.U.), who provided the local unblinded research coordinator with the patient’s group assignment. The unblinded research coordinator notified the patient and, within 48 hours, organized a mutually convenient time for the video consultation with the remote palliative care physician.
Conditions
Community Tele-Pal Intervention
The video consultation intervention protocol, which recommends culturally tailored approaches based on participants’ race (eTable 2 in Supplement 2),43,46 was conducted by a remote palliative care specialist with the patient, caregiver (if available), and unblinded research coordinator using a secure telehealth platform and equipment. Within 24 hours, the remote palliative care clinician entered their consultation note and recommendations on a standardized template (eAppendix 2 in Supplement 2) into the patients’ electronic medical record, which was immediately available to the attending hospitalist. The unblinded research coordinator then followed up in person or by telephone 3 and 6 days following the video consultation with the patient and caregiver to address recommendations or notify the hospitalist about recommendations that needed attention. Research coordinators also documented whether postconsultation recommendations were being followed in the secure REDCap database.49
Video Consultation Fidelity Monitoring
Trained research coordinators and study staff (F.U., C.E.) completed a fidelity checklist (eAppendix 3 in Supplement 2) indicating whether the audiorecorded video consultation visit followed protocol. Fidelity monitoring was completed on each clinician’s first 3 video consultations and a 10% random sample thereafter. Protocol fidelity was excellent (mean [SD] of 89% [0.32%] adherence).
Usual Care
Usual care included all standard hospital procedures, medical care, and referrals (eg, social work) that would be present in a hospital that lacked palliative care services. Usual care was determined at the discretion of the attending hospitalist.
Data Collection and Outcome Measures
An unblinded local research coordinator collected self-reported baseline sociodemographic characteristics and outcome measures prior to randomization. Immediately following the video consultation, patients completed a 10-item telehealth satisfaction questionnaire with a 6-point Likert scale (1, “strongly agree”; 6, “strongly disagree”). Thereafter, a blinded research coordinator collected day 7 and day 30 outcome measures by telephone.
Primary Outcome
The primary outcome was the between-group difference in the change in patient-reported symptom distress from baseline to day 7, measured by the 9-item Edmonton Symptom Assessment Scale (ESAS) (score range, 0-90; lower scores indicate less symptom distress).50 A change of 3 to 4 points in ESAS score from baseline was considered a minimal clinically important difference.51
Secondary Outcomes
Secondary outcomes were patient and caregiver QOL, assessed via the 10-item Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health-10 instrument, version 1.2, which measures physical and mental health.52 Summed raw PROMIS scores are converted to T scores, where 50 is the mean and 10 is the SD (higher scores indicate better health).52 Resource use was measured as self-reported readmissions or emergency visits from discharge until day 30.
Additional caregiver outcomes were caregiver burden, measured by the 14-item Montgomery Borgatta Caregiver Burden Scale with 3 subscales: objective burden (score range, 6-30), demand burden (score range, 4-20), and stress burden (score range, 4-20); higher scores indicate higher burden.53 Satisfaction was measured by the 20-item Family Satisfaction With End-of-Life Care (FAMCARE) Scale on a 5-point Likert scale (1, “very satisfied”; 5, “very dissatisfied”), with a total score range of 20 to 100 (higher scores indicate greater satisfaction).54
Exploratory Outcome
Feeling heard and understood was a single-item measure assessed by the question, “During your hospitalization, how much have you felt/did you feel heard and understood by the doctors, nurses, and hospital staff?” Responses were on a 5-point Likert scale (“completely,” “quite a bit,” “moderately,” “slightly,” or “not at all”).44
Statistical Analysis
Sample Size
We targeted an enrollment of 352 patients (176 per treatment group), resulting in 80% power at α = .05 to detect a standardized effect of 0.3 for the primary outcome and Westfall d (Cohen d with Westfall adjustment,55 used for mixed-effects models) of 0.33 at α = .025 for the secondary and exploratory outcomes (Westfall d of 0.20 was considered small; 0.50, medium; and 0.80, large).56 COVID-19 slowed recruitment rates, so in July 2022, using prior assumptions, the projected recruitment of 250 patients (125 per treatment group) resulted in 80% power at α = .05 to detect a Cohen d of 0.36 for the primary outcome and of 0.40 at α = .025 for the secondary and exploratory outcomes.
Data Analysis
Consistent with an intent-to-treat analysis, all participants were included regardless of participation. We used descriptive statistics (t tests for continuous variables and χ2 tests for categorical variables). For study outcomes, we used mixed models57 with fixed effects of group, time, time × group interaction, and participant random effects to model longitudinal changes. For continuous outcomes, we used a linear mixed model with a normal link function.57 For categorical outcomes, we used a multinomial logistic link function.58 We used a covariance pattern structure57 to model the correlation among repeated measures, with time (day) treated as a categorical measure. We estimated intervention effects by calculating between-group contrasts of the estimated marginal means for the score (for continuous outcomes) or the proportion of patients (for categorical outcomes) at day 7 and day 30, subtracting the baseline value from each. All P values were from 2-sided tests. Results for the primary outcome were deemed statistically significant at P = .05. We also performed a sensitivity analysis using an alternate model to estimate the between-group differences across the follow-up time points, including the baseline value as a covariate for the adjustment as a fixed effect. Data were analyzed using R, version 4.42 (R Project for Statistical Computing).
Results
Participants and Sample Characteristics
Between July 20, 2020, and December 20, 2023, of the 696 patients approached, 487 declined and 209 were randomized (30.0% acceptance rate): 105 to the intervention and 104 to usual care (Figure 1). There were no differences in baseline characteristics between those who consented and those who declined (eTable 3 in Supplement 2). Participant characteristics and patient-reported outcomes were similar between treatment groups (Table 1). Patient participants’ mean (SD) age was 73.3 (8.3) years; 120 (57.4%) were female, and 89 (42.6%) were male. A total of 58 patients (27.8%) self-identified as Black or African American and 151 (72.2%) as White; 157 (75.1%) were retired. Seventy-five (35.9%) had a Palliative Performance Scale (PPS) score less than 70%, indicating reduced function requiring assistance,59 and the mean (SD) Charleson Comorbidity Index score was 4.6 (2.7), indicating moderate to high severity of illness.60,61 Enrolled caregivers (N = 209) had a mean (SD) age of 60.1 (15.1) years; 155 (74.2%) were female, 144 (68.9%) were married, 119 (56.9%) had some college education, and 135 (64.6%) lived with the patient. Baseline caregiver measures were balanced between groups (eTable 4 in Supplement 2).
Figure 1. Participant Flow.

EMR indicates electronic medical record; RC, research coordinator.
Table 1. Patient Baseline Characteristics.
| Characteristic | Participantsa | ||
|---|---|---|---|
| All (N = 209) | Intervention (n = 105) | Usual care (n = 104) | |
| Age, mean (SD), y | 73.3 (8.3) | 72.9 (8.7) | 73.7 (7.7) |
| Gender | |||
| Female | 120 (57.4) | 53 (50.5) | 67 (64.4) |
| Male | 89 (42.6) | 52 (49.5) | 37 (35.6) |
| Raceb | |||
| Black or African American | 58 (27.8) | 30 (28.6) | 28 (26.9) |
| White | 151 (72.2) | 75 (71.4) | 76 (73.1) |
| Marital status | |||
| Married | 104 (49.8) | 60 (57.1) | 44 (42.3) |
| Widowed | 55 (26.3) | 24 (22.9) | 31 (29.8) |
| Divorced | 30 (14.4) | 11 (10.5) | 19 (18.3) |
| Never married | 10 (4.8) | 6 (5.7) | 4 (3.8) |
| Living with a partner | 5 (2.4) | 3 (2.9) | 2 (1.9) |
| Separated | 5 (2.4) | 1 (1.0) | 4 (3.8) |
| Educational level | |||
| ≤Eighth grade | 8 (3.8) | 2 (1.9) | 6 (5.8) |
| Some high school | 46 (22.0) | 29 (27.6) | 17 (16.3) |
| High school graduate or GED | 62 (29.7) | 30 (28.6) | 32 (30.8) |
| Some college or technical school | 57 (27.3) | 25 (23.8) | 32 (30.8) |
| College graduate | 28 (13.4) | 14 (13.3) | 14 (13.5) |
| Graduate degree | 8 (3.8) | 5 (4.8) | 3 (2.9) |
| Employment | |||
| Retired | 157 (75.1) | 74 (70.5) | 83 (79.8) |
| Unemployed (disability) | 33 (15.8) | 18 (17.1) | 15 (14.4) |
| Full time | 9 (4.3) | 7 (6.7) | 2 (1.9) |
| Part time | 7 (3.3) | 5 (4.8) | 2 (1.9) |
| Homemaker | 2 (1.0) | 1 (1.0) | 1 (1.0) |
| Other | 1 (0.5) | 0 | 1 (1.0) |
| Religious preference | |||
| Protestant | 174 (83.3) | 87.0 (82.9) | 87.0 (83.7) |
| Catholic | 10 (4.8) | 6.0 (5.7) | 4.0 (3.8) |
| Jewish | 1 (0.5) | 1.0 (1.0) | 0 |
| Other | 13 (6.2) | 7.0 (6.7) | 6.0 (5.8) |
| None | 11 (5.3) | 4.0 (3.8) | 7.0 (6.7) |
| Insurance status | |||
| Commercial, alone or with additional insurance plan | 25 (12.0) | 17.0 (16.2) | 8.0 (7.7) |
| Medicare, alone or with additional insurance plan | 129 (61.7) | 61.0 (58.1) | 68.0 (65.4) |
| Medicaid, alone or with additional insurance plan | 36 (17.2) | 18.0 (17.1) | 18.0 (17.3) |
| Military, alone or with additional insurance plan | 19 (9.1) | 9.0 (8.6) | 10.0 (9.6) |
| Medical condition | |||
| Cardiac disease | 169 (80.9) | 81 (77.1) | 88 (84.6) |
| Kidney disease | 100 (47.8) | 50 (47.6) | 50 (48.1) |
| Pulmonary disease | 81 (38.8) | 35 (33.3) | 46 (44.2) |
| Cancer | 60 (28.7) | 32 (30.5) | 28 (26.9) |
| Stroke | 29 (13.9) | 13 (12.4) | 16 (15.4) |
| Sepsis | 19 (9.1) | 7 (6.7) | 12 (11.5) |
| Hepatic disease | 11 (5.3) | 7 (6.7) | 4 (3.8) |
| Neurodegenerative disease | 11 (5.3) | 5 (4.8) | 6 (5.8) |
| Other | 26 (12.4) | 12 (11.4) | 14 (13.5) |
| Charlson Comorbidity Index score, mean (SD) | 4.6 (2.7) | 4.6 (2.7) | 4.5 (2.7) |
| Palliative Performance Scale score, % | |||
| 100 | 6 (2.9) | 3 (2.9) | 3 (2.9) |
| 90 | 17 (8.1) | 10 (9.5) | 7 (6.7) |
| 80 | 42 (20.1) | 24 (22.9) | 18 (17.3) |
| 70 | 69 (33.0) | 37 (35.2) | 32 (30.8) |
| 60 | 36 (17.2) | 16 (15.2) | 20 (19.2) |
| 50 | 33 (15.8) | 10 (9.5) | 23 (22.1) |
| 40 | 4 (1.9) | 3 (2.9) | 1 (1.0) |
| 30 | 1 (0.5) | 1 (1.0) | 0 |
| 20 | 1 (0.5) | 1 (1.0) | 0 |
| Length of stay | |||
| Overall | |||
| Total, median (IQR), d | 4.0 (2.0-6.0) | 4.0 (2.0-6.0) | 4.0 (2.0-6.0) |
| Missing, No. | 3 | 1 | 2 |
| Before consultation | |||
| Total, median (IQR), d | NA | 2.0 (2.0-3.0) | NA |
| Missing, No. | NA | 20 | NA |
| After consultation | |||
| Total, median (IQR), d | NA | 1.0 (0.0-3.0) | NA |
| Missing, No. | NA | 21 | NA |
| Patient-reported outcomes | |||
| Primary: ESAS Total Symptom Distress score, mean (SD)c | 36.0 (16.1) | 36.2 (16.8) | 35.9 (15.4) |
| Missing, No. | 4 | 2 | 2 |
| Secondary: PROMIS Global Health-10 scored | |||
| Physical health T score, mean (SD) | 34.9 (8.3) | 35.1 (8.0) | 34.6 (8.5) |
| Mental health T score, mean (SD) | 44.6 (8.0) | 45.5 (7.7) | 43.7 (8.2) |
| Missing, No. | 1 | 1 | 0 |
| Exploratory: feeling heard and understoode | |||
| Completely | 110 (52.6) | 54 (51.4) | 56 (53.8) |
| Quite a bit | 50 (23.9) | 26 (24.8) | 24 (23.1) |
| Moderately | 31 (14.8) | 15 (14.3) | 16 (15.4) |
| Slightly | 10 (4.8) | 7 (6.7) | 3 (2.9) |
| Not at all | 7 (3.3) | 2 (1.9) | 5 (4.8) |
| NA | 1 (0.5) | 1 (1) | 0 |
Abbreviations: ESAS, Edmonton Symptom Assessment Scale; GED, General Educational Development; NA, not applicable; PROMIS, Patient-Reported Outcomes Measurement System.
Data are presented as number (percentage) of participants unless otherwise indicated.
Patients self-identified race using the categories listed. Patients were only eligible if they self-identified as not Hispanic or Latino; thus, this category totals to 100%.
Score ranges from 0 to 90; lower scores indicate less symptom distress.
Scores range from 0 to 100, with a mean (SD) score of 50 (10); higher scores indicate better health.
Single-item measure: “During your hospitalization, how much have you felt/did you feel heard and understood by the doctors, nurses, and hospital staff?”
Of the 105 participants randomized to the intervention, 85 (81.0%) completed the video consultation (Figure 1); there were no demographic differences between those who did and did not receive the video consultation (eTable 5 in Supplement 2). Patient satisfaction with the video consultation technology was 92.7% (eTable 6 and eFigure 1 in Supplement 2).
Study End Points
Primary Outcome
Figure 2 and Table 2 show intervention and usual care mean (SE) ESAS total distress scores at baseline, day 7, and day 30. On day 7, the mean (SE) ESAS score change from baseline was −11.4 (1.5) points in the intervention group and −7.3 (1.5) points in the control group; the between-group difference in change in ESAS scores was not statistically significant (Westfall d, −0.28; 95% CI, −0.56 to 0.01; P = .055). The intervention group’s mean (SE) day 30 ESAS score was not significantly different from that of the usual care group’s (20.8 [1.6] points vs 24.1 [1.6] points; between-group difference in change: Westfall d, −0.24 [95% CI, −0.53 to 0.05]; P = .09); from baseline to day 7 compared with baseline to day 30, there was a greater decrease in the intervention group than in the usual care group. The mean (SE) day 7 between-group difference in ESAS score of −4.2 (2.2) points exceeded the criteria for a minimal clinically important difference of more than 3 to 4 points,51 and the day 30 difference of −3.7 (2.2) points met these criteria. In a sensitivity analysis in which baseline covariates were included in the model (eTable 7 in Supplement 2), the intervention group’s mean (SE) ESAS score at day 7 was significantly different from that of the usual care group’s score (24.5 [1.3] points vs 28.5 [1.3] points; mean [SE] between-group difference in change, −4.0 [1.8] points; Westfall d, 0.33 [95% CI, 0.04-0.62]; P = .02). The mean (SE) day 7 between-group difference in ESAS score of −4.0 (1.8) points met the criteria for a minimal clinically important difference of 3 to 4 points.
Figure 2. Primary Outcome of Total Symptom Distress Measured by the Edmonton Symptom Assessment Scale (ESAS).
Mean scores were estimated using linear mixed effects models. The ESAS score ranges from 0 to 90; lower scores indicate less symptom distress. Whiskers indicate 95% CIs.
Table 2. Change in Symptom Distress and Quality-of-Life Outcomes From Baseline to Day 30 in the Intervention Group vs Usual Care Group.
| Days after baseline | Intervention | Usual care | Between-group difference in change from baselinea | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Participants, No. | Score, mean (SE) | Change from baseline, mean (SE) | Participants, No. | Score, mean (SE) | Change from baseline, mean (SE) | Mean (SE) | Effect size, Westfall d (95% CI)b | P valuec | |
| ESAS total distress scored | |||||||||
| 0 | 103 | 36.3 (1.5) | NA | 102 | 35.9 (1.5) | NA | NA | NA | NA |
| 7 | 94 | 24.9 (1.5) | −11.4 (1.5) | 96 | 28.7 (1.5) | −7.3 (1.5) | −4.2 (2.2) | −0.28 (−0.56 to 0.01) | .055 |
| 30 | 87 | 20.8 (1.6) | 15.5 (1.6) | 91 | 24.1 (1.6) | −11.9 (1.6) | −3.7 (2.2) | −0.24 (−0.53 to 0.05) | .09 |
| PROMIS global physical health T scoree | |||||||||
| 0 | 105 | 35.1 (0.9) | NA | 104 | 34.6 (0.9) | NA | NA | NA | NA |
| 7 | 94 | 38.6 (0.9) | 3.5 (0.8) | 95 | 38 (0.9) | 3.3 (0.8) | 0.2 (1.2) | 0.02 (−0.24 to 0.28) | .87 |
| 30 | 88 | 40.5 (0.9) | 5.4 (0.9) | 90 | 39.4 (0.9) | 4.7 (0.8) | 0.6 (1.2) | 0.07 (−0.19 to 0.34) | .59 |
| PROMIS global mental health T scoree | |||||||||
| 0 | 104 | 45.5 (0.8) | NA | 104 | 43.7 (0.8) | NA | NA | NA | NA |
| 7 | 95 | 45.7 (0.8) | 0.1 (0.7) | 95 | 44 (0.8) | 0.3 (0.7) | −0.1 (1.0) | −0.02 (−0.28 to 0.24) | .88 |
| 30 | 87 | 45.8 (0.8) | 0.2 (0.8) | 93 | 43.9 (0.8) | 0.2 (0.7) | 0.0 (1.1) | 0.00 (−0.26 to 0.27) | .98 |
Abbreviations: ESAS, Edmonton Symptom Assessment Scale; NA, not applicable; PROMIS, Patient-Reported Outcomes Measurement System.
Intervention group minus usual care group; change between groups was calculated as the least-squares mean difference for follow-up (days 7 and 30) minus baseline.
Effect size was calculated as Westfall d for the time × group interaction, and for categorical variables, the Westfall d equivalent was calculated as a transformation of the z statistic and sample size (0.20, small; 0.50, medium; and 0.80, large).
P values are from the time × group interaction term in mixed models.
Score range, 0-90; lower scores indicate lower symptom distress.
The PROMIS Global Health-10 physical and mental health mean (SD) score is 50 (10), and range is 0 to 100; higher scores indicate better health.
Secondary and Exploratory Outcomes
Table 2 shows patient participants’ PROMIS physical and mental health mean (SE) T scores. Baseline intervention vs usual care mean (SE) physical health scores (35.1 [0.9] vs 34.6 [0.9]) were below the adult population mean (SD) of 50 (10) and improved slightly by day 30 (intervention: 40.5 [0.9] points; mean [SE] change, 5.4 [0.9] points; usual care: 39.4 [0.9] points; mean [SE] change, 4.7 [0.8] points), although there was no significant between-group difference in change from baseline (Westfall d, 0.07; 95% CI, −0.19 to 0.34; P = .59). Baseline intervention vs usual care mental health mean (SE) T scores were below the population mean (45.5 [0.8] vs 43.7 [0.8]) and were essentially unchanged by day 30 (45.8 [0.8] vs 43.9 [0.8]; between-group difference in change from baseline: Westfall d, 0.00 [95% CI, −0.26 to 0.27]; P = .98). Caregiver participants’ QOL, FAMCARE, and burden scores were not significantly different between the groups (eTable 8 in Supplement 2).
There were no significant differences between the intervention vs usual care groups at day 30 in median length of stay (4.0 days [IQR, 2.0-6.0 days] for both groups) (Table 1) or mean (SE) number of hospital readmissions (0.20 [0.06] vs 0.14 [0.04]; P = .44) or emergency visits (0.18 [0.06] vs 0.17 [0.05]; P = .84) (Table 3). Video consultation participants had a median length of stay of 2.0 days (IQR, 2.0-3.0 days) before and 1.0 days (IQR, 0.0-3.0 days) after consultation (Table 1).
Table 3. Resource Use From Discharge to Day 30 in the Intervention Group vs Usual Care Group.
| Outcome | Time after baseline, d | Intervention | Usual care | Relative rate (95% CI)a | P valueb | ||
|---|---|---|---|---|---|---|---|
| Participants, No. | Mean (SE), No. | Participants, No. | Mean (SE), No. | ||||
| Emergency visits | 30 | 88 | 0.18 (0.06) | 90 | 0.17 (0.05) | 1.02 (0.87-1.18) | .84 |
| Hospital readmissions | 30 | 90 | 0.20 (0.06) | 91 | 0.14 (0.04) | 1.06 (0.91-1.23) | .44 |
The usual care group was the reference category.
P values are from the group term in zero-inflated Poisson models.
A mean (SE) of 77.7% (4.3%) of patients at baseline and day 30 and of caregivers at day 30 reported feeling completely or quite a bit heard and understood. However, at baseline, a mean (SE) of only 65.1% (5.1%) of caregivers felt completely or quite a bit heard and understood (eTable 9 and eFigure 2 in Supplement 2).
Discussion
In this RCT among Black or African American and White chronically ill hospitalized adults, culturally based specialist palliative care video consultation was not associated with statistically significant reduced symptom distress compared with usual care, but there was a clinically meaningful difference (ESAS score change of 3-4 points) between groups.51 Contrary to our hypotheses, intervention participants’ QOL and resource use (secondary outcomes) also were not improved. To our knowledge, this is one of the first culturally based specialty palliative care video consultation interventions for inpatients in small, rural hospitals in the deep South, few of which have access to palliative care services.7 Increasing rural outpatients’ access to palliative care via telehealth is not new2,9,13; however, telehealth for inpatients has been underdeveloped and understudied.22 The COVID-19 pandemic surge motivated inpatient palliative care via telehealth to conserve personal protective equipment and to promote goals-of-care conversations for intensive care unit patients near death.11,22,25 In contrast, our study, conceived prior to the pandemic, tested culturally based video consultation by palliative care specialists to increase both acceptability and access for rural hospitalized older adults. Our goal was to eliminate disparities due to rurality.7 While our finding of a clinically meaningful reduction in symptom distress is promising, future implementation can only be realized if accompanied by changes in telehealth infrastructure, policy, clinical, administrative, and financial (payment) incentives.20,62 A positive step in that direction is that as of March 2025, the Full-Year Continuing Appropriations and Extensions Act, 202563 passed and will continue through September 30, 2025, extending the flexible telehealth regulations and reimbursement for rural areas with health professional shortages that were instituted during the pandemic.
However, increasing palliative care access via technology alone is insufficient to gain acceptance in rural areas.28,64 Small, rural communities, especially those with predominantly racial and ethnic minority populations, have unique cultures.3 Leveraging multiple community-engaged strategies to develop our intervention and to partner with local CAB members as advisors and recruitment ambassadors34,38,41,46 was essential to getting local community buy-in when introducing potentially beneficial but unfamiliar services such as palliative care.
Our secondary patient QOL and resource use outcomes did not differ significantly at days 7 or 30 compared with usual care, unlike the conclusions from numerous reviews of palliative care studies in cancer65 and noncancer66 diseases.31 There are several plausible explanations for these differences. First, we investigated the short-term effects of a relatively brief inpatient consultation intervention, which was not as robust as the longitudinal outpatient interventions that demonstrated QOL improvements 3 to 6 months after enrollment.31 Second, our intentionally broad eligibility criteria may have identified a heterogenous sample that was not sick enough to show improved QOL or reduced resource use and short-term improved symptom distress. However, an American Hospital Association report67 and a study on rural hospitals68 identified that rural inpatients tended to be older, sicker, and poorer compared with national averages and that most older patients preferred to remain in the local rural hospital rather than be transferred. Furthermore, acute care patients transferred from rural hospitals to larger tertiary centers,69 where palliative care teams are common, tended to be younger and healthier.70,71 Our sample’s baseline characteristics were consistent with moderate to severe illness severity. The mean (SD) Charlson Comorbidity Index score of 4.6 (2.7) corresponds to a moderate to high illness severity, and 35.9% of patients had a PPS score less than 70%. A PPS score of less than 70% has a positive predictive value of 60% to 80% for 6-month mortality (depending on disease), and patients with these scores are generally considered hospice eligible.59 Hence, further research is warranted to evaluate the active ingredients of inpatient palliative care necessary to impact QOL and resource use.70,72
Strengths and Limitations
Important strengths of this study include that the substitution of virtual options to include CAB members as recruitment ambassadors maintained the spirit of engaging community members vs researchers38 as first contact. This approach may have contributed to the overall 30% participation rate and a higher proportion of Black or African American patients relative to the local hospitals’ census.73,74 Additionally, intervention fidelity was excellent, supporting future intervention reproducibility.
Our study also has numerous limitations. First, the potential for selection bias, as the abundance of patients with COVID-19 limited the admissions of typical patient types and led to visitor restrictions, limited our in-person CAB member recruitment approach and contributed to our inability to reach our original recruitment goal. Second, our results may not be generalizable beyond southeastern US non-Hispanic Black or African American or White populations. Third, without an attention control group, we cannot rule out that the additional 1 to 2 hours of attention that the intervention participants received during the video consultation could explain the clinically meaningful reduced symptom distress.
Conclusions
In this RCT, possibly the first prospective, multisite, culturally based palliative care video consultation intervention for hospitalized rural Black or African American and White older adults in the US was associated with clinically meaningful but not statistically significant between-group differences in symptom distress, and QOL and resource use were not affected compared with usual care control participants. These findings warrant further investigation of the effectiveness of culturally based palliative care via video consultation in reducing care disparities for inpatients treated in small rural hospitals without access to palliative care services.
Trial Protocol
eAppendix 1. EMR Screening for Medical Conditions
eTable 1. Study Sites
eTable 2. Culturally Based Consultation Guidelines Linked to NCP Consultation Guidelines
eAppendix 2. Palliative Care Consultation Documentation Template
eAppendix 3. Community Tele-Pal Videoconsultation Fidelity Monitoring Process
eTable 3. Characteristics of Patients Who Consented vs Declined
eTable 4. Caregiver Baseline Demographics and Outcomes
eTable 5. Comparison of Demographics of Intervention Patients Who Completed and Did Not Complete Videoconsultation
eTable 6. Patient Satisfaction With Videoconsultation Technology and Process
eTable 7. ESAS Total Symptom Distress, Intervention vs Usual Care, Adjusted for Baseline
eTable 8. Caregiver Burden, QOL, and FAMCARE From Baseline to 30 Days, Intervention vs Usual Care
eTable 9. Caregiver Heard and Understood From Baseline to 30 Days, Intervention vs Usual Care
eFigure 1. Patient Satisfaction With Technology
eFigure 2. Patients Feeling Heard and Understood
Data Sharing Statement
References
- 1.Aaron SP, Gazaway SB, Harrell ER, Elk R. Disparities and racism experienced among older African Americans nearing end of life. Curr Geriatr Rep. 2021;10(4):157-166. doi: 10.1007/s13670-021-00366-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Bakitas M, Allen Watts K, Malone E, et al. Forging a new frontier: providing palliative care to people with cancer in rural and remote areas. J Clin Oncol. 2020;38(9):963-973. doi: 10.1200/JCO.18.02432 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bassah N, Beranek J, Kennedy M, Onabadejo J, Santos Salas A. Inequities in access to palliative and end-of-life care in the Black population in Canada: a scoping review. Int J Equity Health. 2024;23(1):81. doi: 10.1186/s12939-024-02173-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Connor SR, ed. Global Atlas of Palliative Care. 2nd ed. Worldwide Palliative Care Alliance; 2020. [Google Scholar]
- 5.Ferrell BR, Temel JS, Temin S, et al. Integration of palliative care into standard oncology care: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(1):96-112. doi: 10.1200/JCO.2016.70.1474 [DOI] [PubMed] [Google Scholar]
- 6.Hayes SL, Salzberg CA, McCarthy D, et al. High-need, high-cost patients: who are they and how do they use health care? a population-based comparison of demographics, health care use, and expenditures. Issue Brief (Commonw Fund). 2016;26:1-14. [PubMed] [Google Scholar]
- 7.Silvers A, Sinclair S, Heitner R, Bowman B. America’s readiness to meet the needs of people with serious illness: 2024 Serious Illness Scorecard. August 2024. Accessed May 29, 2025. https://scorecard.capc.org/
- 8.United Health Foundation, American Public Health Association . America’s Health Rankings 2023 Annual Report. 2023. Accessed February 2, 2025. https://assets.americashealthrankings.org/app/uploads/ahr_2023annual_comprehensivereport_final2-web.pdf
- 9.Allen Watts K, Malone E, Dionne-Odom JN, et al. Can you hear me now? improving palliative care access through telehealth. Res Nurs Health. 2021;44(1):226-237. doi: 10.1002/nur.22105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bakitas M, Cheville AL, Mulvey TM, Peppercorn J, Watts K, Dionne-Odom JN. Telehealth strategies to support patients and families across the cancer trajectory. Am Soc Clin Oncol Educ Book. 2021;41:413-422. doi: 10.1200/EDBK_320979 [DOI] [PubMed] [Google Scholar]
- 11.Calton BA, Rabow MW, Branagan L, et al. Top ten tips palliative care clinicians should know about telepalliative care. J Palliat Med. 2019;22(8):981-985. doi: 10.1089/jpm.2019.0278 [DOI] [PubMed] [Google Scholar]
- 12.Stockdill ML, Barnett MD, Taylor R, Dionne-Odom JN, Bakitas M. Telehealth in palliative care: communication strategies from the COVID-19 pandemic. Clin J Oncol Nurs. 2021;25(1):17-22. doi: 10.1188/21.CJON.17-22 [DOI] [PubMed] [Google Scholar]
- 13.Imam SN, Braun UK, Garcia MA, Jackson LK. Evolution of telehealth—its impact on palliative care and medication management. Pharmacy (Basel). 2024;12(2):61. doi: 10.3390/pharmacy12020061 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438-1445. doi: 10.1200/JCO.2014.58.6362 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741-749. doi: 10.1001/jama.2009.1198 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Bakitas MA, Dionne-Odom JN, Ejem DB, et al. Effect of an early palliative care telehealth intervention vs usual care on patients with heart failure: the ENABLE CHF-PC randomized clinical trial. JAMA Intern Med. 2020;180(9):1203-1213. doi: 10.1001/jamainternmed.2020.2861 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Dionne-Odom JN, Azuero A, Lyons KD, et al. Family caregiver depressive symptom and grief outcomes from the ENABLE III randomized controlled trial. J Pain Symptom Manage. 2016;52(3):378-385. doi: 10.1016/j.jpainsymman.2016.03.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Dionne-Odom JN, Azuero A, Lyons KD, et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1446-1452. doi: 10.1200/JCO.2014.58.7824 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dionne-Odom JN, Ejem DB, Wells R, et al. Effects of a telehealth early palliative care intervention for family caregivers of persons with advanced heart failure: the ENABLE CHF-PC randomized clinical trial. JAMA Netw Open. 2020;3(4):e202583. doi: 10.1001/jamanetworkopen.2020.2583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hampton F, Larson J, Hobson A, Hughes D. The role of telemedicine in rural specialty care: priorities and recommendations from rural primary care physicians. Kans J Med. 2024;17(1):6-10. doi: 10.17161/kjm.vol17.21290 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Connolly SL, Miller CJ, Gifford AL, Charness ME. Perceptions and use of telehealth among mental health, primary, and specialty care clinicians during the COVID-19 pandemic. JAMA Netw Open. 2022;5(6):e2216401. doi: 10.1001/jamanetworkopen.2022.16401 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Soliman AA, Akgün KM, Coffee J, et al. Quality of telehealth-delivered inpatient palliative care during the early COVID-19 pandemic. J Pain Symptom Manage. 2023;65(1):6-15. doi: 10.1016/j.jpainsymman.2022.09.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kamal AH, Thienprayoon RM, Aldridge M, et al. Specialty palliative care in COVID-19: early experiences from the Palliative Care Quality Collaborative. J Palliat Med. 2021;24(11):1689-1696. doi: 10.1089/jpm.2020.0440 [DOI] [PubMed] [Google Scholar]
- 24.Ouellet JA, Prsic EH, Spear RA, et al. An observational case series of targeted virtual geriatric medicine and palliative care consults for hospitalized older adults with COVID-19. Ann Palliat Med. 2021;10(6):6297-6306. doi: 10.21037/apm-21-117 [DOI] [PubMed] [Google Scholar]
- 25.Calton B, Abedini N, Fratkin M. Telemedicine in the time of coronavirus. J Pain Symptom Manage. 2020;60(1):e12-e14. doi: 10.1016/j.jpainsymman.2020.03.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Fadul N, Elsayem AF, Bruera E. Integration of palliative care into COVID-19 pandemic planning. BMJ Support Palliat Care. 2021;11(1):40-44. doi: 10.1136/bmjspcare-2020-002364 [DOI] [PubMed] [Google Scholar]
- 27.Hancock S, Preston N, Jones H, Gadoud A. Telehealth in palliative care is being described but not evaluated: a systematic review. BMC Palliat Care. 2019;18(1):114. doi: 10.1186/s12904-019-0495-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.National Coalition for Hospice and Palliative Care . Clinical Practice Guidelines for Quality Palliative Care. 4th ed. 2018. Accessed February 2, 2025. https://www.nationalcoalitionhpc.org/ncp
- 29.Ferrell BR, Twaddle ML, Melnick A, Meier DE. National Consensus Project Clinical Practice Guidelines for Quality Palliative Care Guidelines, 4th Edition. J Palliat Med. 2018;21(12):1684-1689. [DOI] [PubMed] [Google Scholar]
- 30.Beasley A, Bakitas MA, Edwards R, Kavalieratos D. Models of non-hospice palliative care: a review. Ann Palliat Med. 2019;8(suppl 1):S15-S21. doi: 10.21037/apm.2018.03.11 [DOI] [PubMed] [Google Scholar]
- 31.Kavalieratos D, Corbelli J, Zhang D, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016;316(20):2104-2114. doi: 10.1001/jama.2016.16840 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.LoPresti MA, Dement F, Gold HT. End-of-life care for people with cancer from ethnic minority groups: a systematic review. Am J Hosp Palliat Care. 2016;33(3):291-305. doi: 10.1177/1049909114565658 [DOI] [PubMed] [Google Scholar]
- 33.Bakitas MA, Elk R, Astin M, et al. Systematic review of palliative care in the rural setting. Cancer Control. 2015;22(4):450-464. doi: 10.1177/107327481502200411 [DOI] [PubMed] [Google Scholar]
- 34.Gazaway S, Odom JN, Herbey I, et al. Cultural values influence on rural family caregivers’ decision-making for ill older adult loved ones. J Pain Symptom Manage. 2024;68(1):86-95. doi: 10.1016/j.jpainsymman.2024.04.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Smirnova N, Cross SH, Light A, Kavalieratos D. Racial differences in palliative care and hospice among adults with chronic obstructive pulmonary disease. Respir Med. 2024;231:107719. doi: 10.1016/j.rmed.2024.107719 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Turkman YE, Williams CP, Jackson BE, et al. Disparities in hospice utilization for older cancer patients living in the deep South. J Pain Symptom Manage. 2019;58(1):86-91. doi: 10.1016/j.jpainsymman.2019.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Johnson KS. Racial and ethnic disparities in palliative care. J Palliat Med. 2013;16(11):1329-1334. doi: 10.1089/jpm.2013.9468 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Gazaway S, Bakitas M, Underwood F, et al. Community informed recruitment: a promising method to enhance clinical trial participation. J Pain Symptom Manage. 2023;65(6):e757-e764. doi: 10.1016/j.jpainsymman.2023.02.319 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Elk R. Partnering with minoritized communities to reduce health disparities: a focus on advance care planning. J Am Geriatr Soc. 2023;71(8):2369-2372. doi: 10.1111/jgs.18491 [DOI] [PubMed] [Google Scholar]
- 40.Rosa WE, Elk R, Tucker RO. Community-based participatory research in palliative care: a social justice imperative. Lancet Public Health. 2022;7(2):e104. doi: 10.1016/S2468-2667(21)00305-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Gazaway S, Bakitas MA, Elk R, Eneanya ND, Dionne-Odom JN. Engaging African American family caregivers in developing a culturally-responsive interview guide: a multiphase process and approach. J Pain Symptom Manage. 2022;63(6):e705-e711. doi: 10.1016/j.jpainsymman.2022.02.331 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Elk R, Gazaway S. Engaging social justice methods to create palliative care programs that reflect the cultural values of African American patients with serious illness and their families: a path towards health equity. J Law Med Ethics. 2021;49(2):222-230. doi: 10.1017/jme.2021.32 [DOI] [PubMed] [Google Scholar]
- 43.Elk R, Emanuel L, Hauser J, Bakitas M, Levkoff S. Developing and testing the feasibility of a culturally based tele-palliative care consult based on the cultural values and preferences of Southern, rural African American and White community members: a program by and for the community. Health Equity. 2020;4(1):52-83. doi: 10.1089/heq.2019.0120 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gramling R, Stanek S, Ladwig S, et al. ; AAHPM Research Committee Writing Group . Feeling heard and understood: a patient-reported quality measure for the inpatient palliative care setting. J Pain Symptom Manage. 2016;51(2):150-154. doi: 10.1016/j.jpainsymman.2015.10.018 [DOI] [PubMed] [Google Scholar]
- 45.Schulz KF, Altman DG, Moher D; CONSORT Group . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi: 10.1136/bmj.c332 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Watts KA, Gazaway S, Malone E, et al. Community Tele-pal: a community-developed, culturally based palliative care tele-consult randomized controlled trial for African American and White rural Southern elders with a life-limiting illness. Trials. 2020;21(1):672. doi: 10.1186/s13063-020-04567-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387-2392. doi: 10.1001/jama.289.18.2387 [DOI] [PubMed] [Google Scholar]
- 48.Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40(9):771-781. doi: 10.1097/00005650-200209000-00007 [DOI] [PubMed] [Google Scholar]
- 49.REDCap . Accessed April 25, 2025. https://projectredcap.org/
- 50.Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6-9. doi: 10.1177/082585979100700202 [DOI] [PubMed] [Google Scholar]
- 51.Hui D, Shamieh O, Paiva CE, et al. Minimal clinically important difference in the physical, emotional, and total symptom distress scores of the Edmonton Symptom Assessment System. J Pain Symptom Manage. 2016;51(2):262-269. doi: 10.1016/j.jpainsymman.2015.10.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items. Qual Life Res. 2009;18(7):873-880. doi: 10.1007/s11136-009-9496-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Montgomery RJV, Borgatta EF, Borgatta ML. Societal and family change in the burden of care. In: Liu W, Kendig, H, Eds. Who Should Care for the Elderly? Singapore University Press; 2000:27-54.
- 54.Teresi JA, Ornstein K, Ocepek-Welikson K, Ramirez M, Siu A. Performance of the Family Satisfaction With the End-of-Life Care (FAMCARE) measure in an ethnically diverse cohort: psychometric analyses using item response theory. Support Care Cancer. 2014;22(2):399-408. doi: 10.1007/s00520-013-1988-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Westfall J, Kenny DA, Judd CM. Statistical power and optimal design in experiments in which samples of participants respond to samples of stimuli. J Exp Psychol Gen. 2014;143(5):2020-2045. doi: 10.1037/xge0000014 [DOI] [PubMed] [Google Scholar]
- 56.Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Lawrence Erlbaum Associates; 1988. [Google Scholar]
- 57.Brown H, Prescott R. Applied Mixed Models in Medicine. 3rd ed. Wiley; 2015. Statistics in Practice. [Google Scholar]
- 58.Agresti A. Categorical Data Analysis. 3rd ed. Wiley; 2013. Wiley Series in Probability and Statistics; vol 792. [Google Scholar]
- 59.Bischoff KE, Patel K, Boscardin WJ, O’Riordan DL, Pantilat SZ, Smith AK. Prognoses associated with Palliative Performance Scale scores in modern palliative care practice. JAMA Netw Open. 2024;7(7):e2420472. doi: 10.1001/jamanetworkopen.2024.20472 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. doi: 10.1016/0021-9681(87)90171-8 [DOI] [PubMed] [Google Scholar]
- 61.Schneeweiss S, Wang PS, Avorn J, Glynn RJ. Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res. 2003;38(4):1103-1120. doi: 10.1111/1475-6773.00165 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Marbury D. How specialty care is leading the change in telehealth. HealthTech. November 30, 2023. Accessed April 26, 2025. https://healthtechmagazine.net/article/2023/11/how-specialty-care-leading-change-telehealth [Google Scholar]
- 63.Full-Year Continuing Appropriations and Extensions Act, 2025, HR 1968, 119th Cong (2025-2026). Accessed April 26, 2025. https://www.congress.gov/bill/119th-congress/house-bill/1968
- 64.Nalayeh H. Addressing the cultural, spiritual and religious perspectives of palliative care. Ann Palliat Med. 2018;7(suppl 1):AB016. doi: 10.21037/apm.2018.s016 [DOI] [PubMed] [Google Scholar]
- 65.Chow R, Mathews JJ, Cheng EY, et al. Interventions to improve outcomes for caregivers of patients with advanced cancer: a meta-analysis. J Natl Cancer Inst. 2023;115(8):896-908. doi: 10.1093/jnci/djad075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Quinn KL, Shurrab M, Gitau K, et al. Association of receipt of palliative care interventions with health care use, quality of life, and symptom burden among adults with chronic noncancer illness: a systematic review and meta-analysis. JAMA. 2020;324(14):1439-1450. doi: 10.1001/jama.2020.14205 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.American Hospital Association . Rural report: challenges facing rural communities and the roadmap to ensure local access to high-quality, affordable care. February 2019. Accessed February 2, 2025. https://www.aha.org/system/files/2019-02/rural-report-2019.pdf
- 68.Burns M, Bally J, Burles M, Peacock S. Critically ill patients: family experiences of interfacility transfers from rural to urban centers and impact on family relationships. J Fam Nurs. 2023;29(1):74-88. doi: 10.1177/10748407221124254 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Greenwood-Ericksen M, Kamdar N, Lin P, et al. Association of rural and critical access hospital status with patient outcomes after emergency department visits among Medicare beneficiaries. JAMA Netw Open. 2021;4(11):e2134980. doi: 10.1001/jamanetworkopen.2021.34980 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Janberidze E, Poláková K, Bankovská Motlová L, Loučka M. Impact of palliative care consult service in inpatient hospital setting: a systematic literature review. BMJ Support Palliat Care. 2021;11(4):351-360. doi: 10.1136/bmjspcare-2020-002291 [DOI] [PubMed] [Google Scholar]
- 71.Scott M, Shaver N, Lapenskie J, et al. Does inpatient palliative care consultation impact outcomes following hospital discharge? a narrative systematic review. Palliat Med. 2020;34(1):5-15. doi: 10.1177/0269216319870649 [DOI] [PubMed] [Google Scholar]
- 72.Johnson MJ, Rutterford L, Sunny A, et al. Benefits of specialist palliative care by identifying active ingredients of service composition, structure, and delivery model: a systematic review with meta-analysis and meta-regression. PLoS Med. 2024;21(8):e1004436. doi: 10.1371/journal.pmed.1004436 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Aiken Regional Medical Centers. US News & World Report. Accessed April 20, 2025, https://health.usnews.com/best-hospitals/area/sc/aiken-regional-medical-centers-6370008
- 74.Anderson Regional Medical Center. US News & World Report. Accessed May 28, 2025. https://health.usnews.com/best-hospitals/area/ms/anderson-regional-medical-center-6540510
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Trial Protocol
eAppendix 1. EMR Screening for Medical Conditions
eTable 1. Study Sites
eTable 2. Culturally Based Consultation Guidelines Linked to NCP Consultation Guidelines
eAppendix 2. Palliative Care Consultation Documentation Template
eAppendix 3. Community Tele-Pal Videoconsultation Fidelity Monitoring Process
eTable 3. Characteristics of Patients Who Consented vs Declined
eTable 4. Caregiver Baseline Demographics and Outcomes
eTable 5. Comparison of Demographics of Intervention Patients Who Completed and Did Not Complete Videoconsultation
eTable 6. Patient Satisfaction With Videoconsultation Technology and Process
eTable 7. ESAS Total Symptom Distress, Intervention vs Usual Care, Adjusted for Baseline
eTable 8. Caregiver Burden, QOL, and FAMCARE From Baseline to 30 Days, Intervention vs Usual Care
eTable 9. Caregiver Heard and Understood From Baseline to 30 Days, Intervention vs Usual Care
eFigure 1. Patient Satisfaction With Technology
eFigure 2. Patients Feeling Heard and Understood
Data Sharing Statement

